Innovative R&D
Innovative R&D
R&D platform
Hemos Bioscience is committed to independent R&D. After more than a decade of scientific research accumulation, it has built a synthetic biology platform that integrates research capabilities in biotechnology, biochemistry, and bioengineering, which covers core technological processes such as gene recombination, cell factory construction, fermentation, separation and purification.
The company is deepening its collaboration with medical institutions and academic organizations, focusing on original and applied research in the field of recombinant humanized keratin. We are promoting its wide-ranging application in fields such as biopharmaceuticals and beauty & personal care and leveraging synthetic biology to enhance the quality of human life.
Guided by the core principles of “green manufacturing” and “technology empowerment,” the platform leverages an intelligent, high-throughput R&D system to continuously optimize product performance, providing safe and efficient biomaterial solutions for the medical, medical aesthetics, and consumer markets.
Research team
Wang Bochu Founder
Professor, Doctoral Supervisor
Selected as one of the world’s top 2% scientists in 2020, a national-level candidate under the “New Century Hundred-Thousand Talents Project,” and an expert enjoying special allowances from the State Council. Former Dean of the School of Bioengineering at Chongqing University, leader of the National Key Discipline in “Biomedical Engineering,” Deputy Director of the Ministry of Education’s Key Laboratory for “Biomaterials Rheology Technology and Science,” member of the Biomechanics Professional Committee of the Chinese Society of Biomedical Engineering, and Executive Director of the Chongqing Society of Biomedical Engineering.
With a long-term track record in university research and management, Dr.Wang is a dual-driven expert—combining cutting-edge academic research with practical industrial application, processing a top-tier research background, national-level policy support, and extensive experience in engineering-scale technology transfer.
Hao Shilei Chief Scientist
Ph.D. in Biomedical Engineering, Professor, Doctoral Supervisor, Visiting Scholar at the Massachusetts Institute of Technology (MIT) in the United States
Has led numerous national and Chongqing municipal natural science foundation projects, focusing on novel protein design and medical applications (including tissue repair, hemostatic materials, and tumor diagnosis and treatment). With over 10 years of in-depth experience, Dr.Hao profounds academic and industrial expertise in the fields of biomaterials and regenerative medicine.
Having published over 30 SCI papers and holding more than 10 patents, Dr.Hao prossesses both an international, cutting-edge research perspective and extensive experience leading national-level projects, with a long-term focus on technological breakthroughs and clinical translation in biomedical engineering.
Zha Guodong Technical Director
Master of Biomedical Engineering from Chongqing University, Senior Engineer
Deeply engaged in synthetic biology research and its industrial translation, with expertise in the technological development and industrial application of recombinant protein-based materials, covering areas such as process optimization, dosage form development, and medical device registration submissions.
Mr.Zha participated in numerous major national and provincial/ministerial-level R&D projects, published 6 SCI papers, holds more than 10 authorized invention patents, and possesses strong capabilities in translating research findings into practical applications.
Core advantages
Senior Scientist Team
Bringing together top-tier scientists in the field of biomedical engineering, we have been deeply engaged in the Recombinant Keratin area for over a decade, accumulating more than 40 authorized patents and over 100 research achievements. Our global share of SCI papers exceeds 95%, placing us among the industry leaders in research strength.
Advanced preparation process
Using genetic engineering technology, our process circumvents the quality defects inherent in traditional processes and represents a monumental leap forward in keratin preparation technology worldwide over the past century and more.
Large-scale production capacity
Compliant with the ISO9001 production quality system, our production system ensures high-quality, highly stable mass production of Recombinant Keratin and builds a complete “raw material-to-application” industrial chain with significant cost advantages.
R&D Collaboration
Hemos Bioscience continuously deepens its collaborative partnerships with top domestic academic research institutions and medical organizations, building an integrated “industry-academia-research-medical” ecosystem. Focusing on the efficient translation of scientific research findings and driven by continuous scientific innovation, Hemos is leading global innovation in recombinant reconbinant humanized keratin.
Chongqing University
Tsinghua University
Sichuan University
Army Medical University
West China Hospital of Sichuan University
The First Affiliated Hospital of Chongqing Medical University
Xinqiao Hospital Affiliated to the Army Medical University
Chongqing University Affiliated Central Hospital
- Invention patent
- Academic paper
A recombinant keratin injectable gel and a method for its preparation
A recombinant keratin and its applications
A hemostatic protein, its preparation method, and its applications
A stem cell scaffold for use in iron-overload regions and a method for its preparation
A skin wound care ointment and its preparation method
A soluble human keratin and its applications
An Iodine-Containing Disinfectant Based on Keratin and Its Preparation Method
A hydrating night cream containing hydrophilic keratin and a method for its preparation.
A moisturizing serum containing hydrophilic keratin and a method for its preparation
Nanoparticles, toothpaste, and their preparation methods
Keratin, keratin gel dressing for chronic wound healing
Functional Analysis of 17 Types of Hair Keratins—Adv. Funct. Mater. – 2023
Adv Healthcare Materials - 2022 - Wang - Rational Design of High‐Performance Keratin‐Based Hemostatic Agents
Material Design and Self-Assembly: Bioinspired Robust Keratin Hydrogels for Biomedical Applications
Improving Inflammation: The Role of Trichocytic Keratins in Anti-Neuroinflammatory Effects After Spinal Cord Injury—Chongqing Medical University + Asahi Institute of Technology
Hemostasis in Penetrating Trauma: Fabrication of an Expandable Keratin Sponge for Improved Hemostasis in a Penetrating Trauma
Preparation and Hemostatic Performance Study of Keratin Nanohemostatic Powder
Hemostasis and Repair of Brain Injury: An Enhanced Charge-Driven Intranasal Delivery of Nicardipine Attenuates Brain Injury Following Intracerebral Hemorrhage
Hemostatic and Repairing Effects of Brain Injury: Human Hair Keratin Hydrogels Alleviate Rebleeding after Intracerebral Hemorrhage in a Rat Model
Hemostatic and Repairing Brain Injury: In-Situ Hydrogels Enhancing Postoperative Functional Recovery by Reducing Iron Overload After Intracerebral Hemorrhage
Hemostasis and Repair of Brain Injury: Thermo-Sensitive Keratin Hydrogel for Iron-Induced Brain Injury Following Experimental Intracerebral Hemorrhage
Neural Repair: Keratin Nanoparticle-Coated Electrospun PVA Nanofibers for Potential Neural Tissue Applications
Biocompatibility of Keratosepoly (vinyl alcohol)-blended nanofibers: Fabrication and biocompatibility assessment
Gastric Ulcer Repair: Fabrication of an Ulcer-Adhesive Oral Keratin Hydrogel for Gastric Ulcer Healing in Rats
Repair: Feather Keratin Hydrogel for Wound Repair—Preparation, Healing Effect, and Biocompatibility Evaluation
Repair: Recombinant Human Hair Keratin Nanoparticles Accelerate Dermal Wound Healing
Repair: Synthesis and Fabrication of a Keratin-Conjugated Insulin Hydrogel for the Enhancement of Wound Healing
Drug-eluting stent; Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release
Hemostasis: Development and Assessment of Keratin Nanoparticles for Use as a Hemostatic Agent
Hemostasis: Development of feather keratin nanoparticles and investigation of their hemostatic efficacy.
Hemostasis: Recombinant human hair keratin proteins for stopping bleeding
Contact Us
Address: No. 216, Jianshan Road, Biquan Subdistrict, Bishan District, Chongqing City
Website: https://www.hemos.com
Website QR code
Copyright © 2026 Hemos (Chongqing) Bioscience Co., Ltd. All Rights Reserved. Powered by: www.300.cn